Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), a specialty pharmaceutical company, is committed to providing prescription drugs designed to address central nervous system (CNS) disorders. Currently, the company is building a core portfolio of both marketed and development-stage products that attend to substantial, but unmet medical needs. Questcor’s aim is to develop and commercialize their own proprietary products, while staying open to partnering concepts to leverage assets and further build its portfolio. For further information, visit the Company’s web site at www.questcor.com.
- 17 years ago
QualityStocks
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR)
Tags Rodman & Renshaw
Related Post
-
Blockchain Futurist Conference Florida 2025 Kicks Off in Just 2 Weeks, Featuring Iggy Azalea, Tristan Thompson, and Leaders in Web3 & AI
The Blockchain Futurist Conference Florida 2025, now in its eighth edition and first-ever U.S. event,…
-
Fairchild Gold Corp. (TSX.V: FAIR): LOI for Nevada Expansion Strengthens Position Amid Record Gold Outlooks
Memorandum of Understanding signed to acquire the Golden Arrow Project in Nevada’s Walker Lane Belt…
-
BluSky AI Inc. (BSAI) Poised to Reshape AI Infrastructure Deployment While Industry Demand Surges
Google's substantial AI investment in innovation underscores the explosive demand for computing power across the…